Systematic review of tobacco use after lung or head/neck cancer diagnosis: Results and recommendations for future research

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 10, 2015, Pages 1450-1461

  Burris, Jessica L ^a,b   Studts, Jamie L ^a,c   DeRosa, Antonio P ^d   Ostroff, Jamie S ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; META ANALYSIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; REVIEW; SELF REPORT; SMOKING; SYSTEMATIC REVIEW; TOBACCO USE; ADVERSE EFFECTS; EPIDEMIOLOGY; HEAD AND NECK NEOPLASMS; HEALTH; LUNG NEOPLASMS; MEDICAL RESEARCH; MORBIDITY; PRACTICE GUIDELINE; STANDARDS; SURVIVAL RATE; TRENDS;

BIOMEDICAL RESEARCH; GLOBAL HEALTH; GUIDELINES AS TOPIC; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; MORBIDITY; SMOKING; SURVIVAL RATE; TOBACCO USE;

EID: 84942944664     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0257     Document Type: Review

References (194)

1. International Agency for Research on Cancer (IARC) Monograph Working Group on the Evaluation of Carcinogenic Risks to Humans. A review of human carcinogens-Part A: Pharmaceuticals. IARC Monogr Eval Carcinog Risks Hum 2012;100A:1-448.
2. US Department of Health and Human Services. The health consequences of smoking-50 years of progress: A report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Chronic Disease and Control and Prevention, National Center for Chronic Disease Prevention and Control, Office on Smoking and Health; 2014.
3. Duffy SA, Ronis DL, Valenstein M, Fowler KE, Lambert MT, Bishop C, et al. Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics 2007;48:142-8.
4. Balduyck B, Sardari Nia P, Cogen A, Dockx Y, Lauwers P, Hendriks J, et al. The effect of smoking cessation on quality of life after lung cancer surgery. Eur J Cardiothorac Surg 2011;40:1432-8.
5. Garces YI, Yang P, Parkinson J, Zhao XH, Wampfler JA, Ebbert JO, et al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest 2004;126:1733-41.
6. Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RSAACR Subcommittee on Tobacco and Cancer. Assessing tobacco use by cancer patients and facilitating cessation: An American Association for Cancer Research policy statement. Clin Cancer Res 2013;19:1941-8.
7. Hanna NH, Mulshine J, Wollins DS, Tyne C, Dresler C. Tobacco cessation and control a decade later: American Society of Clinical Oncology policy statement update. J Clin Oncol 2013;31:3147-57.
8. International Society of Nurses in Cancer Care. Position statement title: ISNCC tobacco position statement. Vancouver, BC: International Society of Nurses in Cancer Care; 2014.
9. Lin BM, Wang H, D'Souza G, Zhang Z, Fakhry C, Joseph AW, et al. Longterm prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma. Cancer 2013;119:3462-71.
10. Duffy SA, Khan MJ, Ronis DL, Fowler KE, Gruber SB, Wolf GT, et al. Health behaviors of head and neck cancer patients the first year after diagnosis. Head Neck 2008;30:93-102.
11. Moher D, Liberati A, Tetzlaff J, Altman DG The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009;6:e1000097.
12. Browning KK, Ahijevych KL, Ross P Jr., Wewers ME. Implementing the Agency for Health Care Policy and Research's Smoking Cessation Guideline in a lung cancer surgery clinic. Oncol Nurs Forum 2000;27:1248-54.
13. Cox LS, Patten CA, Ebbert JO, Drews AA, Croghan GA, Clark MM, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol 2002;20:3461-9.
14. Duffy SA, Ronis DL, Valenstein M, Lambert MT, Fowler KE, Gregory L, et al. A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 2006; 15:2203-8.
15. Garces YI, Schroeder DR, Nirelli LM, Croghan GA, Croghan IT, Foote RL, et al. Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence - A matched-pair analysis. Cancer 2004;101:116-24.
16. Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LJ, Wong WK, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993;2:261-70.
17. Park ER, Japuntich S, Temel J, Lanuti M, Pandiscio J, Hilgenberg J, et al. A smoking cessation intervention for thoracic surgery and oncology clinics: A pilot trial. J Thorac Oncol 2011;6:1059-65.
18. Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, et al. A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control 2010;21:811-20.
19. Schnoll RA, Rothman RL, Wielt DB, Lerman C, Pedri H, Wang H, et al. A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Ann Behav Med 2005;30:1-11.
20. Sharp L, Johansson H, Fagerstrom K, Rutqvist LE. Smoking cessation among patients with head and neck cancer: cancer as a teachable moment'. Eur J Cancer Care 2008;17:114-9.
21. Stanislaw AE, Wewers ME. A smoking cessation intervention with hospitalized surgical cancer patients: A pilot study. Cancer Nurs 1994;17: 81-6.
22. Wewers ME, Bowen JM, Stanislaw AE, Desimone VB. A nurse-delivered smoking cessation intervention among hospitalized postoperative patients-influence of a smoking-related diagnosis: A pilot study. Heart Lung 1994;23:151-6.
23. Wewers ME, Jenkins L, Mignery T. A nurse-managed smoking cessation intervention during diagnostic testing for lung cancer. Oncol Nurs Forum 1997;24:1419-22.
24. Sanderson Cox L, Patten CA, Ebbert JO, Drews AA, Croghan GA, Clark MM, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol 2002;20:3461-9.
25. Schnoll RA, Zhang B, Rue M, Krook JE, Spears WT, Marcus AC, et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: A trial coordinated by the Eastern Cooperative Oncology Group. J Clin Oncol 2003;21:355-65.
26. Nayan S, Gupta MK, Sommer DD. Evaluating smoking cessation interventions and cessation rates in cancer patients: A systematic review and meta-analysis. ISRN Oncol 2011;2011:849023.
27. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-81.
28. Akerley W, Boucher KM, Bentz JS, Arbogast K, Walters T.Aphase II study of erlotinib as initial treatment for patients with stage IIIB-IV non-small cell lung cancer. J Thorac Oncol 2009;4:214-9.
29. Al-Mamgani A, van Rooij PH, Woutersen DP, Mehilal R, Tans L, Monserez D, et al. Radiotherapy for T1-2N0 glottic cancer: A multivariate analysis of predictive factors for the long-term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients. Clin Otolaryngol 2013;38:306-12.
30. Allison PJ. Factors associated with smoking and alcohol consumption following treatment for head and neck cancer. Oral Oncol 2001;37: 513-20.
31. Asaph JW, Keppel JF, Handy JR Jr, Charles Douville E, Tsen AC, Ott GY. Surgery for second lung cancers. Chest 2000;118:1621-5.
32. Bagan P, Berna P, De Dominicis F, Das Neves Pereira JC, Mordant P, De La Tour B, et al. Nutritional status and postoperative outcome after pneumonectomy for lung cancer. Ann Thorac Surg 2013;95:392-6.
33. Bar-Ad V, Wang ZX, Leiby B, Tuluc M. Combination of p16 levels and preradiotherapy factors predicts outcome in patients treated for oropharyngeal carcinoma. J BUON 2013;18:982-8.
34. Barrera R, Shi W, Amar D, Thaler HT, Gabovich N, Bains MS, et al. Smoking and timing of cessation: impact on pulmonary complications after thoracotomy. Chest 2005;127:1977-83.
35. Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Lin E, et al. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest 2006;130:1784-90.
36. Berg CJ, Thomas AN, Mertens AC, Schauer GL, Pinsker EA, Ahluwalia JS, et al. Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psychooncology 2013;22:799-806.
37. Besse B, Planchard D, Veillard AS, Taillade L, Khayat D, Ducourtieux M, et al. Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer. Lung Cancer 2012;76:78-83.
38. Bjarnason GA, MacKenzie RG, Nabid A, Hodson ID, El-Sayed S, Grimard L, et al. Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: A prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3). Int J Radiat Oncol Biol Phys 2009;73:166-72.
39. Browman GP, Mohide EA, Willan A, Hodson I, Wong G, Grimard L, et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: A follow-up study. Head Neck 2002;24:1031-7.
40. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993;328:159-63.
41. Brown JK. Gender, age, usual weight, and tobacco use as predictors of weight loss in patients with lung cancer. Oncol Nurs Forum 1993;20: 466-72.
42. Browning KK, Wewers ME, Ferketich AK, Otterson GA, Reynolds NR. The self-regulation model of illness applied to smoking behavior in lung cancer. Cancer Nurs 2009;32:E15-E25.
43. Canver CC, Cooler SD, Nichols RD. The influence of cardiopulmonary function on outcome of veterans undergoing resectional therapy for lung cancer. J Cardiovasc Surg 1998;39:497-501.
44. Chan Y, Irish JC, Wood SJ, Sommer DD, Brown DH, Gullane PJ, et al. Smoking cessation in patients diagnosed with head and neck cancer. J Otolaryngolog 2004;33:75-81.
45. Chen AM, Chen LM, Vaughan A, Sreeraman R, Farwell DG, Luu Q, et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys 2011;79:414-9.
46. Chen J, Qi Y, Wampfler JA, Jatoi A, Garces YI, Busta AJ, et al. Effect of cigarette smoking on quality of life in small cell lung cancer patients. Eur J Cancer 2012;48:1593-601.
47. Cheville AL, Novotny PJ, Sloan JA, Basford JR, Wampfler JA, Garces YI, et al. Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancer. J Pain SymptomManage 2011;42:202-12.
48. Cho S, Song IH, Yang HC, Kim K, Jheon S. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg 2013;96:239-45.
49. Christensen AJ, Moran PJ, Ehlers SL, Raichle K, Karnell L, Funk G. Smoking and drinking behavior in patients with head and neck cancer: effects of behavioral self-blame and perceived control. J Behav Med 1999;22:407-18.
50. Colasanto JM, Haffty BG, Wilson LD. Evaluation of local recurrence and second malignancy in patients with T1 and T2 squamous cell carcinoma of the larynx. Cancer J 2004;10:61-6.
51. Cooley ME, Emmons KM, Haddad R, Wang Q, Posner M, Bueno R, et al. Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer. Cancer 2011;117:2961-9.
52. Cooley ME, Sarna L, Brown JK, Williams RD, Chernecky C, Padilla G, et al. Tobacco use in women with lung cancer. Ann Behav Med 2007; 33:242-50.
53. Cooley ME, Sarna L, Kotlerman J, Lukanich JM, Jaklitsch M, Green SB, et al. Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent. Lung Cancer 2009;66:218-25.
54. Cooley ME, Wang Q, Johnson BE, Catalano P, Haddad RI, Bueno R, et al. Factors associated with smoking abstinence among smokers and recentquitters with lung and head and neck cancer. Lung Cancer 2012;76: 144-9.
55. Daniel M, Keefe FJ, Lyna P, Peterson B, Garst J, Kelley M, et al. Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels. J Pain 2009;10:323-8.
56. Day GL, BlotWJ, Shore RE, McLaughlin JK, Austin DF, Greenberg RS, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst 1994;86:131-7.
57. De Boer MF, Van den Borne B, Pruyn JF, Ryckman RM, Volovics L, Knegt PP, et al. Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: results of a 6-year longitudinal study. Cancer 1998;83:2567-79.
58. De Graeff A, De Leeuw JRJ, Ros WJG, Hordijk GJ, Blijham GH, Winnubst JAM. Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Euro J Cancer 2001;37:332-9.
59. De Jesus RR, Meyer TN, Leite ICG, Pereira AAC, Armond MC. Epidemiologic profile and quality of life of patients treated for oral cancer in Juiz de Fora, Minas Gerais, Brazil. MedOral Patol Oral Cir Bucal 2010;15:e20-4.
60. Des Rochers C, Dische S, Saunders MI. The problemof cigarette smoking in radiotherapy for cancer in the head and neck. Clin Oncol (R Coll Radiol) 1992;4:214-6.
61. Ditre JW, Gonzalez BD, Simmons VN, Faul LA, Brandon TH, Jacobsen PB. Associations between pain and current smoking status among cancer patients. Pain 2011;152:60-5.
62. Do KA, Johnson MM, Lee JJ, Wu XF, Dong Q, Hong WK, et al. Longitudinal study of smoking patterns in relation to the development of smokingrelated secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer 2004;101:2837-42.
63. Duffy SA, Ronis DL, McLean S, Fowler KE, Gruber SB, Wolf GT, et al. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol 2009;27:1969-75.
64. Duffy SA, Teknos T, Taylor JM, Fowler KE, Islam M, Wolf GT, et al. Health behaviors predict higher interleukin-6 levels among patients newly diagnosed with head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2013;22:374-81.
65. Eng L, Su J, Qiu X, Palepu PR, Hon H, Fadhel E, et al. Second-hand smoke as a predictor of smoking cessation among lung cancer survivors. J Clin Oncol 2014;32:564-70.
66. Epstein JB, Lunn R, Le ND, Stevenson-Moore P, Gorsky M. Patients with oropharyngeal cancer: A comparison of adults living independently and patients living in long-term care facilities. Spec Care Dentist 2005; 25:124-30.
67. Evangelista LS, Sarna L, Brecht ML, Padilla G, Chen J. Health perceptions and risk behaviors of lung cancer survivors. Heart Lung 2003;32:131-9.
68. Fox JL, Rosenzweig KE, Ostroff JS. The effect of smoking status on survival following radiation therapy for non-small cell lung cancer. Lung Cancer 2004;44:287-93.
69. Fujisawa T, Iizasa T, Saitoh Y, Sekine Y, Motohashi S, Yasukawa T, et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 1999;17:2086-91.
70. Funk GF, Karnell LH, Christensen AJ. Long-term health-related quality of life in survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg 2012;138:123-33.
71. Gosselin MH, Mahoney MC, Cummings KM, Loree TR, Sullivan M, King BA, et al. Evaluation of an intervention to enhance the delivery of smoking cessation services to patients with cancer. J Cancer Educ 2011;26:577-82.
72. Gritz ER, Carr CR, Rapkin DA, Chang C, Beumer J, Ward PH. A smoking cessation intervention for head and neck cancer patients: Trial design, patient accrual, and characteristics. Cancer Epidemiol Biomarkers Prev 1991;1:67-73.
73. Gritz ER, Nisenbaum R, Elashoff RE, Holmes EC. Smoking behavior following diagnosis in patients with stage I non-small cell lung cancer. Cancer Causes Control 1991;2:105-12.
74. Groth SS, Whitson BA, Kuskowski MA, Holmstrom AM, Rubins JB, Kelly RF. Impact of preoperative smoking status on postoperative complication rates and pulmonary function test results 1-year following pulmonary resection for non-small cell lung cancer. Lung Cancer 2009;64:352-7.
75. Hald J, Overgaard J, Grau C. Evaluation of objectivemeasures of smoking status-a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy. Acta Oncol 2003;42:154-9.
76. Hay J, Ostroff J, Burkhalter J, Li Y, Quiles Z, Moadel A. Changes in cancerrelated risk perception and smoking across time in newly-diagnosed cancer patients. J Behav Med 2007;30:131-42.
77. Hernando ML, Marks LB, Bentel GC, Zhou SM, Hollis D, Das SK, et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001; 51:650-9.
78. Hirao T, Nelson HH, Ashok TD, Wain JC, Mark EJ, Christiani DC, et al. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer. Cancer Res 2001;61:612-5.
79. Hocevar-Boltezar I, Zargi M, Strojan P. Risk factors for voice quality after radiotherapy for early glottic cancer. Radiother Oncol 2009;93:524-9.
80. Hopenhayn C, Christian WJ, Christian A, Studts J, Mullet T. Factors associated with smoking abstinence after diagnosis of early stage lung cancer. Lung Cancer 2013;80:55-61.
81. Jazieh AR, Foraida M, Ghouse M, Khalil MM, Kopp M, Savidge M. The impact of cancer diagnosis on the lifestyle and habits of patients served at a Veterans Administration Hospital. J Cancer Educ 2006;21:147-50.
82. Jerjes W, Upile T, Radhi H, Petrie A, Abiola J, Adams A, et al. The effect of tobacco and alcohol and their reduction/cessation on mortality in oral cancer patients: short communication. Head Neck Oncol 2012;4:6.
83. Johnston-Early A, Cohen MH, Minna JD. Smoking abstinence and small cell lung cancer survival: An association. JAMA 1980;244:2175-9.
84. Kashigar A, Habbous S, Eng L, Irish B, Bissada E, Irish J, et al. Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients. Cancer 2013;119:2701-9.
85. Kawaguchi T, Matsumura A, Iuchi K, Ishikawa S, Maeda H, Fukai S, et al. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy. Jpn J Clin Oncol 2006;36:7-11.
86. Kawahara M, Ushijima S, Kamimori T, Kodama N, Ogawara M, Matsui K, et al. Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: The role of smoking cessation. Br J Cancer 1998;78:409-12.
87. Kerawala CJ. Oral cancer, smoking and alcohol: The patients' perspective. Br J Oral Maxillofac Surg 1999;37:374-6.
88. Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 2001;10:823-9.
89. Khuri FR, Lee JJ, Lippman SM, Kim ES, Cooper JS, Benner SE, et al. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 2006;98:441-50.
90. Kikidis D, Vlastarakos PV, Manolopoulos L, Yiotakis I. Continuation of smoking after treatment of laryngeal cancer: An independent prognostic factor? ORL J Otorhinolaryngol Relat Spec 2012;74:250-4.
91. Kim AJ, Suh JD, Sercarz JA, Abemayor E, Head C, Funk G, et al. Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma. Laryngoscope 2007;117:1019-23.
92. Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH. Aberrantmethylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung. Carcinogenesis 2004;25:2165-71.
93. Kim JS, Lee H, Kim H, Shim YM, Han J, Park J, et al. Promoter methylation of retinoic acid receptor beta 2 and the development of second primary lung cancers in non-small-cell lung cancer. J Clin Oncol 2004;22:3443-50.
94. Koczywas M, Cristea M, Thomas J, McCarty C, Borneman T, Del Ferraro C, et al. Interdisciplinary palliative care intervention in metastatic nonsmall- cell lung cancer. Clin Lung Cancer 2013;14:736-44.
95. Lambert MT, Terrell JE, Copeland LA, Ronis DL, Duffy SA. Cigarettes, alcohol, and depression: characterizing head and neck cancer survivors in two systems of care. Nicotine Tob Res 2005;7:233-41.
96. Landi MT, Dracheva T, Rotunno M, Figueroa JD, Liu H, Dasgupta A, et al. Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival. PLoS One 2008;3:e1651.
97. Lebel S, Feldstain A, McCallum M, Beattie S, Irish J, Bezjak A, et al. Do behavioural self-blame and stigma predict positive health changes in survivors of lung or head and neck cancers? Psychol Health 2013;28: 1066-81.
98. Leon X, Venegas MDP, Orus C, Lopez M, Garcia J, Quer M. Influence of the persistence of tobacco and alcohol use in the appearance of second neoplasm in patients with a head and neck cancer: A case-control study. Cancer Causes Control 2009;20:645-52.
99. Logan HL, Fillingim RB, Bartoshuk LM, Sandow P, Tomar SL, Werning JW, et al. Smoking status and pain level among head and neck cancer patients. J Pain 2010;11:528-34.
100. Magn N, Marcy PY, Chamorey E, Guardiola E, Pivot X, Schneider M, et al. Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long-term quality of life analysis. Head Neck 2001;23:678-82.
101. Marin VP, Pytynia KB, Langstein HN, Dahlstrom KR, Wei Q, Sturgis EM. Serum cotinine concentration and wound complications in head and neck reconstruction. Plast Reconstr Surg 2008;121:451-7.
102. Mason DP, Subramanian S, Nowicki ER, Grab JD, Murthy SC, Rice TW, et al. Impact of smoking cessation before resection of lung cancer: A Society of Thoracic Surgeons general thoracic surgery database study. Ann Thorac Surg 2009;88:362-71.
103. Mayne ST, Cartmel B, Kirsh V, Goodwin WJ Jr. Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx. Cancer Epidemiol Biomarkers Prev 2009;18:3368-74.
104. Meyer F, Bairati I, Fortin A, Gelinas M, Nabid A, Brochet F, et al. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: A randomized trial among head and neck cancer patients. Int J Cancer 2008;122:1679-83.
105. Miller KL, Zhou SM, Barrier RC Jr, Shafman T, Folz RJ, Clough RW, et al. Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2003; 56:611-5.
106. Morales NA, Romano MA, Cummings KM, Marshall JR, Hyland AJ, Hutson A, et al. Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control 2013;24:1223-30.
107. Myrdal G, Lambe M, Gustafsson G, Nilsson K, Stahle E. Survival in primary lung cancer potentially cured by operation: influence of tumor stage and clinical characteristics. Ann Thorac Surg 2003;75:356-63.
108. Nagy-Mignotte H, Guillem P, Vesin A, Toffart AC, Colonna M, Bonneterre V, et al. Primary lung adenocarcinoma: characteristics by smoking habit and sex. Eur Respir J 2011;38:1412-9.
109. Nakamura H, Haruki T, Adachi Y, Fujioka S, Miwa K, Taniguchi Y. Smoking affects prognosis after lung cancer surgery. Surg Today 2008; 38:227-31.
110. Nia PS, Weyler J, Colpaert C, Vermeulen P, Van Marck E, Van Schil P. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer 2005;47:351-9.
111. Osthus AA, Aarstad AK, Olofsson J, Aarstad HJ. Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 2013;139:14-20.
112. Ostroff JS, Jacobsen PB, Moadel AB, Spiro RH, Shah JP, Strong EW, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 1995;75:569-76.
113. Paris C, Benichou J, Saunier F, Metayer J, Brochard P, Thiberville L, et al. Smoking status, occupational asbestos exposure and bronchial location of lung cancer. Lung Cancer 2003;40:17-24.
114. Petty WJ, Laudadio J, Brautnick L, Lovato J, Dotson T, Streer NP, et al. Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer. Int J Oncol 2013;43:2057-63.
115. Poveda-Roda R, Bagan JV, Jimenez-Soriano Y, Margaix-Munoz M, Sarrion- Perez G. Changes in smoking habit among patients with a history of oral squamous cell carcinoma (OSCC). Med Oral Patol Oral Cir Bucal 2010;15:e721-6.
116. Rades D, Setter C, Dahl O, Schild SE, Noack F. The prognostic impact of tumor cell expression of estrogen receptor-alpha, progesterone receptor, and androgen receptor in patients irradiated fornonsmall cell lung cancer. Cancer 2012;118:157-63.
117. Rades D, Setter C, Dahl O, Schild SE, Noack F. Fibroblast growth factor 2- A predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012;82:442-7.
118. Rades D, Setter C, Schild SE, Dunst J. Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;71:1134-42.
119. Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg 2003;76:1001-8.
120. Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993;119:383-90.
121. Sanderson Cox L, Sloan JA, Patten CA, Bonner JA, Geyer SM, McGinnis WL, et al. Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer. Psychooncology 2002;11:472-8.
122. Sandhu S, Humphris G, Whitley S, Cardozo A, Sandhu A. Smoking habits in patients who have been treated for an oral cancer: validation of selfreport using saliva cotinine. Oral Oncol 2004;40:576-8.
123. Sandoval M, Font R, Manos M, Dicenta M, Quintana MJ, Bosch FX, et al. The role of vegetable and fruit consumption and other habits on survival following the diagnosis of oral cancer: A prospective study in Spain. Int J Oral Maxillofac Surg 2009;38:31-9.
124. Sarihan S, Ercan I, Saran A, Cetintas SK, Akalin H, Engin K. Evaluation of infections in non-small cell lung cancer patients treated with radiotherapy. Cancer Detect Prev 2005;29:181-8.
125. Sarna L. Smoking behaviors of women after diagnosis with lung cancer. Image J Nurs Sch 1995;27:35-41.
126. Sarna L, Cooley ME, Brown JK, Chernecky C, Padilla G, Danao L, et al. Women with lung cancer: quality of life after thoracotomy: A 6-month prospective study. Cancer Nurs 2010;33:85-92.
127. Sarna L, Lindsey AM, Dean H, Brecht ML, McCorkle R. Weight change and lung cancer: relationships with symptom distress, functional status, and smoking. Res Nurs Health 1994;17:371-9.
128. Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L. Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol 2002;20:2920-9.
129. Schnoll RA, James C, Malstrom M, Rothman RL, Wang H, Babb J, et al. Longitudinal predictors of continued tobacco use among patients diagnosed with cancer. Ann Behav Med 2003;25:214-22.
130. Schnoll RA, Malstrom M, James C, Rothman RL, Miller SM, Ridge JA, et al. Processes of change related to smoking behavior among cancer patients. Cancer Pract 2002;10:11-9.
131. Schnoll RA, Malstrom M, James C, Rothman RL, Miller SM, Ridge JA, et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns 2002;46:137-45.
132. Schnoll RA, Subramanian S, Martinez E, Engstrom PF. Correlates of continued tobacco use and intention to quit smoking among Russian cancer patients. Int J Behav Med 2011;18:325-32.
133. Shuman AG, Duffy SA, Ronis DL, Garetz SL, McLean SA, Fowler KE, et al. Predictors of poor sleep quality among head and neck cancer patients. Laryngoscope 2010;120:1166-72.
134. Siddiqui F, Pajak TF, Watkins-Bruner D, Konski AA, Coyne JC, Gwede CK, et al. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: A radiation therapy oncology group analysis. Int J Radiat Oncol Biol Phys 2008;70:353-60.
135. Simmons VN, Litvin EB, Jacobsen PB, Patel RD, McCaffrey JC, Oliver JA, et al. Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer 2013;119:1420-7.
136. Spitz MR, Fueger JJ, Chamberlain RM, Goepfert H, Newell GR. Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers. J Cancer Educ 1990;5:109-13.
137. Sridhar KS, Raub WA Jr. Present and past smoking history and other predisposing factors in 100 lung cancer patients. Chest 1992;101: 19-25.
138. Stevens MH, Gardner JW, Parkin JL, Johnson LP. Head and neck cancer survival and life-style change. Arch Otolaryngol 1983;109:746-9.
139. Su CK, Wang CC. Prognostic value of Chinese race in nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 2002;54:752-8.
140. Terhaard CH, Snippe K, Ravasz LA, van der Tweel I, Hordijk GJ. Radiotherapy in T1 laryngeal cancer: prognostic factors for locoregional control and survival, uni- And multivariate analysis. Int J Radiat Oncol Biol Phys 1991;21:1179-86.
141. Thompson TL, Pagedar NA, Karnell LH, Funk GF. Factors associated with mortality in 2-year survivors of head and neck cancer. Arch Otolaryngol Head Neck Surg 2011;137:1100-5.
142. Tomek MS, McGuirt WF. Second head and neck cancers and tobacco usage. Am J Otolaryng 2003;24:24-7.
143. Tromp DM, Brouha XDR, Hordijk GJ, Winnubst JAM, Gebhardt WA, Van Der Doef MP, et al. Medical care-seeking and health-risk behavior in patients with head and neck cancer: The role of health value, control beliefs and psychological distress. Health Educ Res 2005;20:665-75.
144. Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer 2006;106:2428-36.
145. Vander Ark W, DiNardo LJ, Oliver DS. Factors affecting smoking cessation in patients with head and neck cancer. Laryngoscope 1997;107:888-92.
146. Vergnenegre A, Monnet I, Chouaid C, Hureaux J, Mazieres J, Quere G, et al. Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: A GFPC study. Lung Cancer 2011;74:264-7.
147. Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol 2003;21:1544-9.
148. Videtic GMM, Truong PT, Ash RB, Yu EW, Kocha WI, Vincent MD, et al. Does sex influence the impact that smoking, treatment interruption and impaired pulmonary function have on outcomes in limited stage small cell lung cancer treatment? Can Respir J 2005;12:245-50.
149. Walker MS, Vidrine DJ, Gritz ER, Larsen RJ, Yan Y, Govindan R, et al. Smoking relapse during the first year after treatment for early-stage nonsmall- cell lung cancer. Cancer Epidemiol Biomarkers Prev 2006;15: 2370-7.
150. Westra WH, Offerhaus GJA, Goodman SN, Slebos RJC, Polak M, Baas IO, et al. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol 1993;17:213-20.
151. Yano T, Shoji F, Baba H, Koga T, Shiraishi T, Orita H, et al. Significance of the urinary 8-OHdG level as an oxidative stress marker in lung cancer patients. Lung Cancer 2009;63:111-4.
152. Zevallos JP, Mallen MJ, Lam CY, Karam-Hage M, Blalock J, Wetter DW, et al. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. Cancer 2009;115: 4636-44.
153. Park ER, Japuntich SJ, Rigotti NA, Traeger L, He Y, Wallace RB, et al. A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer 2012;118:3153-64.
154. Poullis M, McShane J, Shaw M, Shackcloth M, Page R, Mediratta N, et al. Smoking status at diagnosis and histology type as determinants of longterm outcomes of lung cancer patients. Eur J Cardiothorac Surg 2013; 43:919-24.
155. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86:1119-27.
156. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Addiction 1989;84:791-800.
157. Browning KK, Ferketich AK, Otterson GA, Reynolds NR, Wewers ME. A psychometric analysis of quality of life tools in lung cancer patients who smoke. Lung Cancer 2009;66:134-9.
158. Agaku IT, King BA, Dube SR. Current cigarette smoking among adults - United States, 2005-2012. MMWR 2014;63:29-34.
159. Giovino GA, Schooley MW, Zhu BP, Chrismon JH, Tomar SL, Peddicord JP, et al. Surveillance for selected tobacco-use behaviors-United States, 1900-1994. MMWR 1994;43:1-43.
160. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoking and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.
161. Warren GW, Alberg AJ, Kraft AS, Cummings KM. The 2014 Surgeon General's Report: "The health consequences of smoking-50 years of progress": A paradigm shift in cancer care. Cancer 2014;120: 1914-6.
162. Warren GW, Marshall JR, Cummings KM, Toll B, Gritz ER, Hutson A, et al. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol 2013;8: 543-8.
163. Warren GW, Marshall JR, Cummings KM, Toll BA, Gritz ER, Hutson A, et al. Addressing tobacco use in patients with cancer: A survey of American Society of Clinical Oncology members. J Oncol Prac 2013; 9:258-62.
164. Fiore MC, Baker TB. Treating smokers in the health care setting. N Engl J Med 2011;365:1222-31.
165. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz WC, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Rockville, MD: United States Public Health Service; 2008.
166. Duffy SA, Louzon SA, Gritz ER. Why do cancer patients smoke and what can providers do about it? Community Oncol 2012;9:344-52.
167. Hughes J, Keely J, Niaura R, Ossip-Klein D, Richmond R, Swan G. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003;5:13-26.
168. Choi WS, Okuyemi KS, Kaur H, Ahluwalia JS. Comparison of smoking relapse curves among African-American smokers. Addict Behav 2004;29:1679-83.
169. Hughes JR, Keely J, Naud S. Shape of the relapse curve and longterm abstinence among untreated smokers. Addiction 2004;99: 29-38.
170. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev 2005;14:2287-93.
171. Peters EN, Torres E, Toll B, Cummings KM, Gritz ER, Hyland A, et al. Tobacco assessment in actively accruing National Cancer Institute cooperative group program clinical trials. J Clin Oncol 2012;30: 2869-75.
172. National Cancer Institute [Internet]. Bethesda, MD: National Cancer Institute; [updated 2015 Jun 11; cited 2015 Jun 12]. NCI-AACR cancer patient tobacco use questionnaire. Available from: https://www.gemmeasures.org/Public/MeasureDetail.aspx?mid=2003&cat=2.
173. National Comprehensive Cancer Network. National Comprehensive Cancer Network clinical practice guidelines in oncology: smoking cessation, version 1.2015. Fort Washington, PA: National Comprehensive Cancer Network; 2015.
174. Dasgupta P, Kinkade R, Joshi B, DeCook C, Haura E, Chellappan S. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by upregulating XIAP and survivin. Proc Natl Acad Sci U S A 2006;103: 6332-7.
175. Warren GW, Rangnekar VM, McGarry R, Arnold SA, Kudrimoti M. Pathways of resistance: potential effects of nicotine on cancer treatment response. Int J Radiat Oncol Biol Phys 2008;72(S715).
176. Warren GW, Romano MA, Kudrimoti MR, Randall ME, McGarry RC, Singh AK, et al. Nicotinic modulation of therapeutic response in vitro and in vivo. Int J Cancer 2012;131:2519-27.
177. Warren GW, Arnold SM, Valentino JP, Gal TJ, Hyland AJ, Singh AK, et al. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol 2012;103:45-8.
178. Stratton K, Shetty P, Wallace RB, Bondurant S. Clearing the smoke: The science base for tobacco harm reduction-executive summary. Tob Control 2001;10:189-95.
179. Boyle RG, Saint Claire AW, Kinney AM, D'Silva J, Carusi C. Concurrent use of cigarettes and smokeless tobacco in Minnesota. J Environ Public Health 2012;2012:493109.
180. Popova L, Ling PM. Alternative tobacco product use and smoking cessation: A national study. Am J Public Health 2013;103:923-30.
181. Pearson JL, Richardson A, Niaura RS, Vallone DM, Abrams DB. E-cigarette awareness, use, and harm perceptions in US adults. Am J Public Health 2012;102:1758-66.
182. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life: A 24-month prospective observational study. Intern Emerg Med 2013;9: 537-46.
183. Bhattacharyya N. Trends in the use of smokeless tobacco in United States, 2000-2010. Laryngoscope 2012;122:2175-8.
184. Borland R, Li L, Cummings KM, O'Connor R, Mortimer K, Wikmans T, et al. Effects of a Fact Sheet on beliefs about the harmfulness of alternative nicotine delivery systems compared with cigarettes. Harm Reduct J 2012;9:19.
185. Hatsukami DK, Jensen J, Anderson A, Broadbent B, Allen S, Zhang Y, et al. Oral tobacco products: preference and effects among smokers. Drug Alcohol Depend 2011;118:230-6.
186. Lund KE, McNeill A, Scheffels J. The use of snus for quitting smoking compared with medicinal products. Nicotine Tob Res 2010;12: 817-22.
187. Timberlake DS, Pechmann C, Tran SY, Au V. A content analysis of Camel Snus advertisements in print media. Nicotine Tob Res 2011;13: 431-9.
188. O'Connor RJ, Norton KJ, Bansal-Travers M, Mahoney MC, Cummings KM, Borland R. US smokers' reactions to a brief trial of oral nicotine products. Harm Reduct J 2011;8:1.
189. Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer 2014; 120:3527-35.
190. Tomar SL, Alpert HR, Connolly GN. Patterns of dual use of cigarettes and smokeless tobacco among US males: findings from national surveys. Tob Control 2010;19:104-9.
191. Lund KE, McNeill A. Patterns of dual use of snus and cigarettes in amature snus market. Nicotine Tob Res 2013;15:678-84.
192. Zhu S-H, Wang JB, Hartman A, Zhuang Y, Gamst A, Gibson JT, et al. Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results? Tob Control 2009;18:82-7.
193. Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer 2006;106:17-27.
194. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: The case of smoking cessation. Health Educ Res 2003;18:156-70.